12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·04/20/2026 17:05:50
Listen to the news
Gainers
Enveric Biosciences (NASDAQ:ENVB) shares increased by 132.7% to $4.24 during Monday's regular session. The company's market cap stands at $2.5 million.
Psyence Biomedical (NASDAQ:PBM) shares rose 92.23% to $14.61. The market value of their outstanding shares is at $7.7 million.
Theriva Biologics (AMEX:TOVX) shares rose 75.23% to $0.45. The company's market cap stands at $11.8 million.
Clearmind Medicine (NASDAQ:CMND) stock rose 59.82% to $1.15. The company's market cap stands at $1.7 million.
Compass Pathways (NASDAQ:CMPS) stock increased by 49.32% to $9.95. The market value of their outstanding shares is at $898.5 million.
Cue Biopharma (NASDAQ:CUE) shares increased by 30.74% to $0.79. The company's market cap stands at $59.2 million.
Losers
Passage Bio (NASDAQ:PASG) stock decreased by 36.3% to $7.43 during Monday's regular session. The market value of their outstanding shares is at $37.0 million.
AnaptysBio (NASDAQ:ANAB) shares decreased by 25.85% to $50.06. The company's market cap stands at $1.8 billion.
Nano X Imaging (NASDAQ:NNOX) stock fell 25.26% to $2.13. The company's market cap stands at $166.7 million. As per the press release, Q4 earnings came out today.
CEL-SCI (AMEX:CVM) shares declined by 23.24% to $3.8. The market value of their outstanding shares is at $41.8 million.
Agios Pharmaceuticals (NASDAQ:AGIO) stock declined by 23.14% to $27.01. The company's market cap stands at $2.0 billion.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.